There is no shortage of opportunity in Indonesia’s healthcare market, but there is a very real shortage of time for foreign exporters entering without a strategy.
Indonesia’s demand for medical technology is surging. The national health insurance program (JKN) now covers approximately 90% of the population, and the government’s Cek Kesehatan Gratis (CKG) health screening initiative targets a massive 130 million participants in 2026 alone.
For foreign medical device exporters, this is a clear market signal. Diagnostic equipment, laboratory devices, surgical tools, and patient monitoring systems are in active, government-backed demand.
However, this window of opportunity closes quickly if regulatory delays occur. Without proper preparation, a standard AKL registration for moderate-to-high-risk devices can drag on for 6 to 18 months.
To move quickly, navigating the Ministry of Health’s (MoH) fast-track medical device registration process is essential. This structured, expedited pathway can cut months off the standard timeline, provided you leverage the right local License Holder structure from day one.
This guide breaks down exactly who qualifies, which device categories are prioritized, and how the License Holder scheme works in practice to accelerate your market entry.
What Is the Fast-Track Pathway for Medical Devices in Indonesia?
The fast-track pathway is an expedited medical device review mechanism offered by Indonesia’s Ministry of Health under the Regalkes system.
This pathway is not universally available. It is granted under specific regulatory conditions designed to serve urgent public health needs, national health program priorities, and government procurement targets.
Under Peraturan Menteri Kesehatan No. 62 Tahun 2017 (Minister of Health Regulation No. 62 of 2017), the legal basis for medical device registration is established. Within this framework, the MoH has the authority to accelerate review timelines for devices deemed critical or strategically important.
Subsequent MoH circulars and technical guidelines have further defined which categories and conditions are eligible.
Rather than going through standard dossier queues, a fast-track submission receives prioritized reviewer assignment and compressed clarification windows, provided all documentation is complete, correctly formatted, and submitted by a recognized local License Holder.
Special Access Requirements from the Ministry of Health
The MoH does not grant fast-track access automatically. Several conditions must be met for a submission to qualify.
These requirements apply to both the product being registered and the local entity holding the license.
1. The License Holder Must Be Fully Compliant
Since July 1, 2024, the MoH has enforced a firm rule: any company submitting a new medical device registration must hold a valid CDAKB (Cara Distribusi Alat Kesehatan yang Baik) certificate. Companies without an active CDAKB certification are ineligible to register products, regardless of device urgency or market status.
For foreign exporters, this means their chosen local partner must already have this certification in place before submission.
2. Complete Dossier at First Submission
Fast-track review is forfeited if the dossier is incomplete at the time of submission. The MoH will not hold expedited slots for files requiring repeated rounds of clarification. Required documents typically include:
- Letter of Authorization (LoA) from the original manufacturer
- Certificate of Free Sale (CFS) from the country of origin
- ISO 13485 certification
- Technical documentation aligned with the ASEAN Common Submission Dossier Template (CSDT)
- Bahasa Indonesia labeling and Instructions for Use (IFU)
- Risk analysis documentation appropriate to the device class
3. Legalized Supporting Documents
All foreign regulatory documents, including the CFS, GMP certificates, and LoA, must be notarized and legalized through an Indonesian Embassy or apostilled before they are accepted through the Regalkes portal. This step alone can take months if started late.
4. Device Classification Accuracy
Misclassification is one of the most common causes of delay in any registration, fast-track or otherwise. Indonesia uses a risk-based classification system aligned with the ASEAN Medical Device Directive (AMDD), placing devices into Class A (low risk) through Class D (high risk). The fast-track medical device license review is more accessible for Class A and Class B devices, while Class C and D submissions require stronger clinical and technical evidence.
Priority Categories: Which Medical Devices Qualify for Fast-Track?
The MoH gives expedited attention to devices that align with national health program goals.
Based on current MoH priorities and procurement demands, the following categories are most commonly eligible for accelerated review consideration:
Diagnostics and In Vitro Diagnostic (IVD) Devices
Point-of-care test kits, blood analyzers, and pathology equipment directly support the CKG and JKN programs. These products are actively sought by government hospitals and community health centers (Puskesmas).
Imaging Equipment
X-ray systems, ultrasound machines, and CT/MRI-related devices are prioritized as the government expands cardiology, oncology, and intensive care infrastructure.
Patient Monitoring Systems
Vital signs monitors, ECG devices, and ICU monitoring equipment are in continuous demand as new government hospitals come online across provinces beyond Java.
Infection Control and Sterilization Devices
Given post-pandemic health reform priorities, devices supporting hygiene, sterilization, and infection prevention remain elevated in MoH’s review priority list.
Surgical and Implantable Devices (Class C/D)
While these require more rigorous documentation, they are strategically important and can benefit from expedited processing if the submitting License Holder has an established track record with the MoH.
The Local Authorised Representative Scheme for Medical Devices in Indonesia
This is the part that trips up most foreign exporters entering Indonesia for the first time.
Indonesian law is explicit: a foreign manufacturer cannot register a medical device under its own name. Registration must be held by an Indonesian legal entity. This entity is responsible for regulatory compliance, post-market obligations, and communication with the MoH throughout the product’s lifecycle.
Historically, most exporters solved this by appointing their Indonesian distributor as the license holder. This approach is still common, but it creates a serious commercial vulnerability.
If the distributor relationship sours or the manufacturer wants to expand to additional distribution channels, the registered license belongs to the distributor. Changing the license holder requires reapplication, which restarts the AKL registration timeline from scratch.
How does a Local Authorised Representative Work?
As an independent Local Authorised Representative or License Holder, we are a locally registered company fully equipped with IDAK (Izin Distribusi Alat Kesehatan) and CDAKB certifications.
It acts as the official registered entity for the foreign manufacturer’s products without being involved in sales, distribution, or commercial negotiations.
This separation is the key advantage. The foreign manufacturer can appoint multiple distributors, negotiate freely, and even transition to its own Indonesian entity later, all without disrupting the product’s registration status.
We manage:
- Dossier preparation and Regalkes submission
- Government fee (PNBP) payment and tracking
- MoH clarification responses and reviewer communication
- Post-market surveillance reporting
- License renewal (every 5 years)
- License transfer to the manufacturer’s own entity when ready
The Regulatory Framework Behind the Fast-Track System
Understanding the legal grounding helps exporters prepare with confidence.
Peraturan Menteri Kesehatan No. 62 of 2017 remains the primary legal basis for medical device registration in Indonesia. It establishes the NIE (Nomor Izin Edar) as the mandatory approval required before any device can be imported, marketed, or sold.
Presidential Regulation No. 10 of 2021 opened the door for foreign investors to hold majority or full ownership of companies engaged in medical device importation and registration. This has made PT PMA (foreign-owned local entities) a more viable long-term market entry route, with an independent local authorised representative providing the bridge during the setup phase.
Arahan Alat Kesehatan ASEAN (AMDD) alignment means that manufacturers with CE Mark or FDA clearance already have a documentation foundation to build on, though full Indonesian registration is still required. CE or FDA approval alone does not grant market access.
CDAKB Enforcement (2024 Update): Since mid-2024, the MoH has enforced strict CDAKB pre-certification for all new registrations. Recent enforcement has removed the possibility of using unaudited local distributors as license holders, increasing the importance of specialized License Holder firms.
The AKL Registration Timeline Reality
Many foreign exporters underestimate how early the regulatory process must begin. The AKL registration timeline does not start when the manufacturer is ready to sell. It starts the moment the decision to enter Indonesia is made, or earlier.
Here is why:
- Embassy legalization and document apostilling can take 2 to 6 months, depending on the country of origin
- ISO 13485 certificate verification requires additional time for authentication
- LoA validity must cover a full 5-year term to align with NIE registration validity
- Class C and D devices may require local clinical evidence or laboratory testing, adding 3 to 6 months
For exporters targeting government procurement or the LKPP e-Katalog, the registered NIE is a prerequisite. There is no shortcut around it. The only true acceleration lever is starting early and ensuring the License Holder is ready, certified, and experienced.
How Product Registration Indonesia Supports Fast-Track Submissions?
Product Registration Indonesia serves as an independent, neutral License Holder for foreign manufacturers entering the Indonesian medical device market.
With active IDAK and CDAKB certifications, we are fully authorized to submit new registrations immediately, without the waiting period that unqualified local distributors face.
Our regulatory team handles every stage of the medical device registration process in Indonesia, from initial product classification and dossier gap analysis to Regalkes submission, MoH clarification management, and NIE issuance.
Importantly, our License Holder arrangement is distributor-neutral. Foreign manufacturers retain full commercial freedom to appoint, replace, or expand their distribution network without affecting their product’s registration status.
When a manufacturer is ready to establish its own Indonesian entity, we support a structured license transfer to ensure continuity.
For manufacturers with multiple product lines, we also provide portfolio-level strategies, including product grouping to maximize efficiency across submissions.
Our team includes medically qualified regulatory specialists with direct experience in MoH dossier review expectations, which means clarification responses are faster, more precise, and less likely to trigger rejection cycles.
The Opportunity Is Real. The Window Is Now.
Indonesia’s healthcare market is one of the most dynamic in Asia. Government investment in public health infrastructure, universal insurance coverage, and the country’s expanding network of hospitals and diagnostic centers make it a market that forward-looking manufacturers cannot afford to delay.
But the medical device registration process in Indonesia is not forgiving of late starts, incomplete dossiers, or the wrong local partner. The fast-track pathway exists. The License Holder structure works.
The question is whether exporters access it correctly or spend 12 to 18 months finding out what they should have done differently.
For foreign exporters who want to move with confidence, clarity, and speed, we are ready to map out the right pathway for their device portfolio from day one.
Frequently Asked Questions (FAQs)
1. What is the difference between the standard and fast-track medical device registration process in Indonesia?
The standard pathway follows the regular MoH review queue and can take 9 to 18 months, depending on the device class and dossier quality. The fast-track pathway, or Jalur Cepat, offers expedited review for devices that fall within MoH priority categories and whose submissions are complete at the time of filing. Accessing the fast-track route requires a fully certified License Holder (with active IDAK and CDAKB) and a complete, correctly formatted dossier from the outset.
2. What is the AKL registration timeline, and what affects how long it takes?
The AKL registration timeline refers to the period from initial submission to NIE issuance. For Class A/B devices submitted via the fast-track pathway with a complete dossier, approval can come within 3 to 7 months. Standard submissions for Class C/D devices typically require 12 to 18 months. Key factors affecting the timeline include document legalization delays, dossier completeness, MoH clarification cycles, and whether the License Holder has an active CDAKB certification.
3. Which medical device categories are currently prioritized for fast-track review by Indonesia’s Ministry of Health?
The MoH currently prioritizes devices that support national health programs such as JKN and the Cek Kesehatan Gratis initiative. These include diagnostic and IVD devices, medical imaging systems, patient monitoring equipment, infection control tools, and certain surgical instruments. Diagnostic test kits, laboratory analyzers, and imaging devices for public hospitals tend to receive the most consistent fast-track consideration, particularly when submitted by a well-credentialed License Holder with prior MoH approval history.
4. Is CDAKB certification mandatory, and who needs to hold it?
Yes. Since July 1, 2024, CDAKB (Good Distribution Practice for Medical Devices) certification is a mandatory prerequisite for any new medical device registration submission in Indonesia. The CDAKB must be held by the Indonesian legal entity submitting the registration, which is either the distributor or the independent License Holder. Foreign manufacturers cannot hold CDAKB directly. Using a pre-certified License Holder firm removes this barrier entirely and enables immediate submission eligibility.
